{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:35:18Z","timestamp":1777635318213,"version":"3.51.4"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1994,11,1]],"date-time":"1994-11-01T00:00:00Z","timestamp":783648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporosis Int"],"published-print":{"date-parts":[[1994,11]]},"DOI":"10.1007\/bf01622190","type":"journal-article","created":{"date-parts":[[2005,4,30]],"date-time":"2005-04-30T17:36:38Z","timestamp":1114882598000},"page":"320-322","source":"Crossref","is-referenced-by-count":132,"title":["Pamidronate: An unrecognized problem in gastrointestinal tolerability"],"prefix":"10.1007","volume":"4","author":[{"given":"E. G.","family":"Lufkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Argueta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. D.","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. L.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. S.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. M.","family":"O'Fallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. L.","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00003495-199141020-00009","volume":"41","author":"A Fitton","year":"1991","unstructured":"Fitton A, McTavish D. Pamidronate: a review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 1991;41:289\u2013318.","journal-title":"Drugs"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/pgmj.66.781.918","volume":"66","author":"SJ Gallacher","year":"1990","unstructured":"Gallacher SJ, Ralston SH, Dryburgh FJ, et al. Immobilization-related hypercalcaemia: a possible novel mechanism and response to pamidronate. Postgrad Med J 1990;66:918\u201322.","journal-title":"Postgrad Med J"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(87)92555-4","volume":"2","author":"ATh Holten-Verzantvoort van","year":"1987","unstructured":"van Holten-Verzantvoort ATh, Bijvoet OLM, Hermans J, et al. Reduced morbidity from skeletal metastases in breast cancer patients during long-term bisphosphonate (APD) treatment. Lancet 1987;2:983\u20135.","journal-title":"Lancet"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/0277-5379(91)90212-V","volume":"27","author":"ATM Holten-Verzantvoort van","year":"1991","unstructured":"van Holten-Verzantvoort ATM, Zwinderman AH, Aaronson NK, et al. The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer 1991;27:544\u20139.","journal-title":"Eur J Cancer"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/bjc.1990.25","volume":"61","author":"DJ Dodwell","year":"1990","unstructured":"Dodwell DJ, Howell A, Ford J. Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate. Br J Cancer 1990;61:123\u20135.","journal-title":"Br J Cancer"},{"key":"CR6","first-page":"79","volume":"217","author":"HIJ Harinck","year":"1987","unstructured":"Harinck HIJ, Bijvoet OLM, Blanksma HJ, Dahlinghaus-Hienhuys PJ. Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone. Clin Orthop 1987;217:79\u201398.","journal-title":"Clin Orthop"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0169-6009(89)90095-0","volume":"5","author":"R Valkema","year":"1989","unstructured":"Valkema R, Vismans F-JFE, Papapoulos SE, et al. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 1989;5:183\u201392.","journal-title":"Bone Miner"},{"key":"CR8","doi-asserted-by":"crossref","unstructured":"Reid IR, King AR, Alexander CJ, et al. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet 1988; :143\u20136.","DOI":"10.1016\/S0140-6736(88)92721-3"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbmr.5650050611","volume":"5","author":"IR Reid","year":"1990","unstructured":"Reid IR, Schooler BA, Stewart AW. Prevention of glucocorticoid-induced osteoporosis. J Bone Miner Res 1990;5:619\u201323.","journal-title":"J Bone Miner Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01625440","volume":"1","author":"GA Fromm","year":"1991","unstructured":"Fromm GA, Vega E, Plantalech L, et al. Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis. Osteoporosis Int 1991;1:129\u201333.","journal-title":"Osteoporosis Int"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0140-6736(76)91158-2","volume":"2","author":"KT Evans","year":"1976","unstructured":"Evans KT, Roberts GN. Where do all the tablets go? Lancet 1976;2:1237\u20139.","journal-title":"Lancet"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-117-2-133","volume":"117","author":"DS Indorf","year":"1992","unstructured":"Indorf DS, Pegram PS. Esophageal ulceration related to zalcitabine (ddC). Ann Intern Med 1992;117:133\u20134.","journal-title":"Ann Intern Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01622190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01622190\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01622190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T12:34:15Z","timestamp":1556886855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01622190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,11]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1994,11]]}},"alternative-id":["BF01622190"],"URL":"https:\/\/doi.org\/10.1007\/bf01622190","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,11]]}}}